116 related articles for article (PubMed ID: 29144944)
1. Re: Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
Taneja SS
J Urol; 2017 Dec; 198(6):1209-1210. PubMed ID: 29144944
[No Abstract] [Full Text] [Related]
2. Comparison of
Regula N; Kostaras V; Johansson S; Trampal C; Lindström E; Lubberink M; Velikyan I; Sörensen J
Sci Rep; 2020 Mar; 10(1):4993. PubMed ID: 32193430
[TBL] [Abstract][Full Text] [Related]
3. Comparison of
Calais J; Fendler WP; Herrmann K; Eiber M; Ceci F
J Nucl Med; 2018 May; 59(5):789-794. PubMed ID: 29242404
[TBL] [Abstract][Full Text] [Related]
4.
Fitzpatrick C; Lynch O; Marignol L
Anticancer Res; 2017 Jun; 37(6):2753-2760. PubMed ID: 28551611
[TBL] [Abstract][Full Text] [Related]
5. Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer.
Minamimoto R; Hancock S; Schneider B; Chin FT; Jamali M; Loening A; Vasanawala S; Gambhir SS; Iagaru A
J Nucl Med; 2016 Apr; 57(4):557-62. PubMed ID: 26659347
[TBL] [Abstract][Full Text] [Related]
6. Impact of
Hope TA; Aggarwal R; Chee B; Tao D; Greene KL; Cooperberg MR; Feng F; Chang A; Ryan CJ; Small EJ; Carroll PR
J Nucl Med; 2017 Dec; 58(12):1956-1961. PubMed ID: 28522741
[TBL] [Abstract][Full Text] [Related]
7. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.
Perera M; Papa N; Roberts M; Williams M; Udovicich C; Vela I; Christidis D; Bolton D; Hofman MS; Lawrentschuk N; Murphy DG
Eur Urol; 2020 Apr; 77(4):403-417. PubMed ID: 30773328
[TBL] [Abstract][Full Text] [Related]
8. Potential Impact of
Calais J; Kishan AU; Cao M; Fendler WP; Eiber M; Herrmann K; Ceci F; Reiter RE; Rettig MB; Hegde JV; Shaverdian N; King CR; Steinberg ML; Czernin J; Nickols NG
J Nucl Med; 2018 Nov; 59(11):1714-1721. PubMed ID: 29653978
[TBL] [Abstract][Full Text] [Related]
9. [The role of molecular imaging (PET-CT) in the diagnostic and treatment pf prostate cancer].
Mirzaei S; Knoll P; Zandieh S
Wien Med Wochenschr; 2019 Feb; 169(1-2):12-14. PubMed ID: 30349972
[TBL] [Abstract][Full Text] [Related]
10. [Ga-68-PSMA PET/CT for prostate cancer].
Hellwig D; Moosbauer J; Eilles C
Aktuelle Urol; 2014 Nov; 45(6):457-63. PubMed ID: 25518963
[TBL] [Abstract][Full Text] [Related]
11. Whole-Body Integrated [
Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
[TBL] [Abstract][Full Text] [Related]
12.
Ceci F; Castellucci P; Graziani T; Farolfi A; Fonti C; Lodi F; Fanti S
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):31-39. PubMed ID: 30350010
[TBL] [Abstract][Full Text] [Related]
13. (68)Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer.
Eiber M; Nekolla SG; Maurer T; Weirich G; Wester HJ; Schwaiger M
Abdom Imaging; 2015 Aug; 40(6):1769-71. PubMed ID: 25412869
[TBL] [Abstract][Full Text] [Related]
14.
Wang R; Shen G; Yang R; Ma X; Tian R
Eur J Radiol; 2020 Sep; 130():109131. PubMed ID: 32622250
[TBL] [Abstract][Full Text] [Related]
15. Dynamic patterns of [
Alberts I; Sachpekidis C; Gourni E; Boxler S; Gross T; Thalmann G; Rahbar K; Rominger A; Afshar-Oromieh A
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):160-167. PubMed ID: 31628514
[TBL] [Abstract][Full Text] [Related]
16.
Pfister D; Haidl F; Nestler T; Verburg F; Schmidt M; Wittersheim M; Steib F; Heidenreich A
BJU Int; 2020 Dec; 126(6):679-683. PubMed ID: 32531840
[TBL] [Abstract][Full Text] [Related]
17. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
Yilmaz B; Turkay R; Colakoglu Y; Baytekin HF; Ergul N; Sahin S; Tugcu V; Inci E; Tasci AI; Cermik TF
Prostate; 2019 Jun; 79(9):1007-1017. PubMed ID: 31012125
[TBL] [Abstract][Full Text] [Related]
18. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy.
Boreta L; Gadzinski AJ; Wu SY; Xu M; Greene K; Quanstrom K; Nguyen HG; Carroll PR; Hope TA; Feng FY
Urology; 2019 Jul; 129():165-171. PubMed ID: 30928607
[TBL] [Abstract][Full Text] [Related]
19. Frusemide aids diagnostic interpretation of
Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):739-744. PubMed ID: 28623852
[TBL] [Abstract][Full Text] [Related]
20. Multiphasic
Beheshti M; Manafi-Farid R; Geinitz H; Vali R; Loidl W; Mottaghy FM; Langsteger W
J Nucl Med; 2020 Oct; 61(10):1484-1490. PubMed ID: 32060214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
